The Open Virology Journal




(Discontinued)

ISSN: 1874-3579 ― Volume 15, 2021

Herpesvirus Vectors in Gene Therapy



Veijo HukkanenRole: Guest Editor
Address: Department of Virology University of Turku Kiinamyllynkatu 13 FIN-20520 Turku Finland veijo.hukkanen@utu.fi


Article Information


Identifiers and Pagination:

Year: 2010
Volume: 4
First Page: 94
Last Page: 95
Publisher Id: TOVJ-4-94
DOI: 10.2174/1874357901004010094

Article History:

Electronic publication date: 18/6/2010
Collection year: 2010

© Veijo Hukkanen; Licensee Bentham Open.

open-access license: This is an open access article licensed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited.






Herpes simplex virus type 1 (HSV-1) is a common human virus, best known as the causative agent of recurrent labial herpes (cold sores) [1Roizman B, Knipe DM, Whitley R. Herpes simplex viruses In: Knipe DM, Howley P, Griffin D, Eds. Fields Virology. 5th. Philadelphia: Lippincott Williams & Wilkins 2007; pp. 2501-601.]. The unique properties of HSV-1 have increasingly been exploited in vector design, particularly for therapy of the central nervous system diseases.

HSV has natural properties useful for a therapy vector: the latent, life-long infections in the nervous system with long-term gene expression, the episomal non-integrating DNA genome and the numerous dispensable genes allowing cloning of large transgenes and their regulatory sequences [2Roizman B. The function of herpes simplex virus genes: A primer for genetic engineering of novel vectors Proc Natl Acad Sci USA 1996; 93: 11307-2.]. Numerous clinical phase I-III studies using HSV vectors are in progress on therapy of gliomas and other malignancies and of other, mainly neurological, disorders, including pain [3Gene Therapy Clinical Trials Worldwide http://www.wiley.co.uk/genmed/clinical [Accessed: 12 April 2010];, 4Glorioso JC, Fink DJ. Herpes vector-mediated gene transfer in the treatment of chronic pain Mol Ther 2009; 17: 13-8.].

The HSV vectors can be genomic, nonreplicating or replicative vectors, or HSV amplicons. HSV amplicons are vectors harboring only minimal amount of virally derived sequences, suitable for delivery of up to 150 kbp of foreign DNA [5Epstein AL. Progress and prospects: biological properties and technological advances of herpes simplex virus type 1-based amplicon vectors Gene Ther 2009; 16: 709-15.]. The use of HSV amplicon vectors has further been improved by the development of HSV-adeno-associated virus (AAV) hybrid vectors, aiming at long-term transgene expression. The wild type HSV, and also the HSV vectors, can evoke both innate and adaptive immune responses in the host organism [6Chew T, Taylor K, Mossman KL. Innate and adaptive immune responses to herpes simplex virus Viruses 2009; 1: 979-1002.]. The host responses can limit the vector persistence and duration of the transgene expression, but may occasionally also be advantageous in therapy of certain diseases. The current special issue introduces to the reader the different types and uses of HSV vectors, as well as the host responses which may affect the performance of these vectors.

In this issue, Tsitoura and Epstein provide an expert overview of the HSV amplicon vectors and the host responses. They discuss the challenges in overcoming the amplicon silencing in the host, as well as the roles of certain HSV genes in counteracting the host responses. The review by de Oliveira and Fraefel introduces the HSV/AAV hybrid vectors, and illustrates also the biology of AAV and AAV vectors. The relevant helper viruses and HSV vectors are discussed, and new hybrid virus vectors are presented, such as HSV/Epstein-Barr virus and HSV/retrovirus hybrids. The overview by Cassady and Parker elucidates the use of HSV in tumor killing. They present the conditionally replicating HSV vectors for brain tumor therapy. In their paper, various approaches are illustrated for enhancement of tumor killing by HSV, such as combination of HSV virotherapy with other therapeutic modalities, or the tumor-specific targeting of HSV vectors. The authors discuss strategies to facilitate replication of HSV vectors in malignant cells without restoration of neurovirulence. In an extensive review, Manservigi et al. elucidate the design and applications of recombinant HSV vectors, with an emphasis on the genomic HSV vectors. They present the key issues of the HSV life cycle relevant to the vector development and introduce the different types of HSV vectors. The applications of HSV vectors are described in therapy of chronic diseases of the nervous system, in cancer therapy and also in vaccine vector design. The targeting strategies and means of imaging of HSV vectors are illustrated, and the authors also discuss the host responses and other factors compromizing the HSV vector efficacy. New perspectives for HSV-mediated tumor therapy are discussed, including the exploitation of microRNAs.

This special issue of The Open Virology Journal presents state-of-the-art reviews by experts of the HSV vector field, covering the different types and uses of HSV vectors and elucidating the central questions such as vector design and targeting, silencing of the transgenes and other effects of the host responses. Hopefully this special issue is useful for the readership; for those interested in applications of HSV and for those considering the choice of viral vector for their particular gene therapy purpose.

ACKNOWLEDGEMENTS

The financial support from the Academy of Finland is acknowledged (grant #128915). I thank Dr. Henrik Paavilainen for critical discussions.

REFERENCES
[1] Roizman B, Knipe DM, Whitley R. Herpes simplex viruses In: Knipe DM, Howley P, Griffin D, Eds. Fields Virology. 5th. Philadelphia: Lippincott Williams & Wilkins 2007; pp. 2501-601.
[2] Roizman B. The function of herpes simplex virus genes: A primer for genetic engineering of novel vectors Proc Natl Acad Sci USA 1996; 93: 11307-2.
[3] Gene Therapy Clinical Trials Worldwide http://www.wiley.co.uk/genmed/clinical [Accessed: 12 April 2010];
[4] Glorioso JC, Fink DJ. Herpes vector-mediated gene transfer in the treatment of chronic pain Mol Ther 2009; 17: 13-8.
[5] Epstein AL. Progress and prospects: biological properties and technological advances of herpes simplex virus type 1-based amplicon vectors Gene Ther 2009; 16: 709-15.
[6] Chew T, Taylor K, Mossman KL. Innate and adaptive immune responses to herpes simplex virus Viruses 2009; 1: 979-1002.
Track Your Manuscript:


Endorsements



"Open access will revolutionize 21st century knowledge work and accelerate the diffusion of ideas and evidence that support just in time learning and the evolution of thinking in a number of disciplines."


Daniel Pesut
(Indiana University School of Nursing, USA)

"It is important that students and researchers from all over the world can have easy access to relevant, high-standard and timely scientific information. This is exactly what Open Access Journals provide and this is the reason why I support this endeavor."


Jacques Descotes
(Centre Antipoison-Centre de Pharmacovigilance, France)

"Publishing research articles is the key for future scientific progress. Open Access publishing is therefore of utmost importance for wider dissemination of information, and will help serving the best interest of the scientific community."


Patrice Talaga
(UCB S.A., Belgium)

"Open access journals are a novel concept in the medical literature. They offer accessible information to a wide variety of individuals, including physicians, medical students, clinical investigators, and the general public. They are an outstanding source of medical and scientific information."


Jeffrey M. Weinberg
(St. Luke's-Roosevelt Hospital Center, USA)

"Open access journals are extremely useful for graduate students, investigators and all other interested persons to read important scientific articles and subscribe scientific journals. Indeed, the research articles span a wide range of area and of high quality. This is specially a must for researchers belonging to institutions with limited library facility and funding to subscribe scientific journals."


Debomoy K. Lahiri
(Indiana University School of Medicine, USA)

"Open access journals represent a major break-through in publishing. They provide easy access to the latest research on a wide variety of issues. Relevant and timely articles are made available in a fraction of the time taken by more conventional publishers. Articles are of uniformly high quality and written by the world's leading authorities."


Robert Looney
(Naval Postgraduate School, USA)

"Open access journals have transformed the way scientific data is published and disseminated: particularly, whilst ensuring a high quality standard and transparency in the editorial process, they have increased the access to the scientific literature by those researchers that have limited library support or that are working on small budgets."


Richard Reithinger
(Westat, USA)

"Not only do open access journals greatly improve the access to high quality information for scientists in the developing world, it also provides extra exposure for our papers."


J. Ferwerda
(University of Oxford, UK)

"Open Access 'Chemistry' Journals allow the dissemination of knowledge at your finger tips without paying for the scientific content."


Sean L. Kitson
(Almac Sciences, Northern Ireland)

"In principle, all scientific journals should have open access, as should be science itself. Open access journals are very helpful for students, researchers and the general public including people from institutions which do not have library or cannot afford to subscribe scientific journals. The articles are high standard and cover a wide area."


Hubert Wolterbeek
(Delft University of Technology, The Netherlands)

"The widest possible diffusion of information is critical for the advancement of science. In this perspective, open access journals are instrumental in fostering researches and achievements."


Alessandro Laviano
(Sapienza - University of Rome, Italy)

"Open access journals are very useful for all scientists as they can have quick information in the different fields of science."


Philippe Hernigou
(Paris University, France)

"There are many scientists who can not afford the rather expensive subscriptions to scientific journals. Open access journals offer a good alternative for free access to good quality scientific information."


Fidel Toldrá
(Instituto de Agroquimica y Tecnologia de Alimentos, Spain)

"Open access journals have become a fundamental tool for students, researchers, patients and the general public. Many people from institutions which do not have library or cannot afford to subscribe scientific journals benefit of them on a daily basis. The articles are among the best and cover most scientific areas."


M. Bendandi
(University Clinic of Navarre, Spain)

"These journals provide researchers with a platform for rapid, open access scientific communication. The articles are of high quality and broad scope."


Peter Chiba
(University of Vienna, Austria)

"Open access journals are probably one of the most important contributions to promote and diffuse science worldwide."


Jaime Sampaio
(University of Trás-os-Montes e Alto Douro, Portugal)

"Open access journals make up a new and rather revolutionary way to scientific publication. This option opens several quite interesting possibilities to disseminate openly and freely new knowledge and even to facilitate interpersonal communication among scientists."


Eduardo A. Castro
(INIFTA, Argentina)

"Open access journals are freely available online throughout the world, for you to read, download, copy, distribute, and use. The articles published in the open access journals are high quality and cover a wide range of fields."


Kenji Hashimoto
(Chiba University, Japan)

"Open Access journals offer an innovative and efficient way of publication for academics and professionals in a wide range of disciplines. The papers published are of high quality after rigorous peer review and they are Indexed in: major international databases. I read Open Access journals to keep abreast of the recent development in my field of study."


Daniel Shek
(Chinese University of Hong Kong, Hong Kong)

"It is a modern trend for publishers to establish open access journals. Researchers, faculty members, and students will be greatly benefited by the new journals of Bentham Science Publishers Ltd. in this category."


Jih Ru Hwu
(National Central University, Taiwan)

Browse Contents



Table of Contents


Webmaster Contact: info@benthamopen.net
Copyright © 2023 Bentham Open